Generic Gleevec Will Likely Cut Millions in Health Costs

FRIDAY, March 18, 2016 — Using the generic form of the cancer drug Gleevec could save patients and insurers millions of dollars, a new study suggests.
The patent on Gleevec expired in January. The generic version of the drug is called imatinib.
Source: Topamax